Review of Primary and Secondary Prevention Trials with Lovastatin, Pravastatin, and Simvastatin
- 5 September 2005
- journal article
- review article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 96 (5), 34-38
- https://doi.org/10.1016/j.amjcard.2005.06.010
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The Case for Intensive Statin Therapy After Acute Coronary SyndromesThe American Journal of Cardiology, 2005
- Different Time Course for Prevention of Coronary and Stroke Events by Atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid-Lowering Arm (ASCOT-LLA)The American Journal of Cardiology, 2005
- Effect of Intensive Lipid Lowering on Progression of Coronary Atherosclerosis: Evidence for an Early Benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) TrialThe American Journal of Cardiology, 2005
- Update on Statins: 2003Circulation, 2004
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Optimal low-density lipoprotein is 50 to 70 mg/dlJournal of the American College of Cardiology, 2004
- Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)JAMA, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998